A
$ Value
$0
Shares
27,812
Price
$0
Filed
Jul 2
Insider
Name
Issa Mohamed Khairie
Title
EVP, Head of US Oncology
CIK
0002050035
Roles
Officer
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
76,483
Footnotes
Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years from the vesting commencement date of January 6, 2025. The RSUs may be settled only for shares of common stock on a one-for-one basis. | Including the June 30, 2025 grant, this includes an aggregate of 76,483 shares of common stock issuable pursuant to previously reported RSUs that have not vested.
Filing Info
Issa Mohamed Khairie's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-15 | INCY | A | $0 |
| 2025-07-15 | INCY | A | $0 |
| 2025-07-15 | INCY | A | $0 |
| 2025-06-30 | INCY | A | $0 |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HARRIGAN EDMUND | — | — | 2026-03-31 |
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |